Factor ix non-recombinant
Products billed under this code include Alphanine SD.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Alphanine SD.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Alphanine SD | Grifols USA, LLC | 68516-3610-02 | 1 | $1.412 |
| Alphanine SD | Grifols USA, LLC | 68516-3611-02 | 1 | $1.412 |
| Alphanine SD | Grifols USA, LLC | 68516-3612-02 | 1 | $1.412 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.412 | +$0.009 | 1 IU | Factor ix non-recombinant | v1, posted September 17, 2026 |
| 3Q26 | $1.403 | +$0.034 | 1 IU | Factor ix non-recombinant | v1, posted September 15, 2026 |
| 2Q26 | $1.369 | +$0.001 | 1 IU | Factor ix non-recombinant | v1, posted September 15, 2026 |
| 1Q26 | $1.368 | −$0.029 | 1 IU | Factor ix non-recombinant | v1, posted September 15, 2026 |
| 4Q25 | $1.397 | +$0.062 | 1 IU | Factor ix non-recombinant | v1, posted September 8, 2026 |
| 3Q25 | $1.335 | −$0.042 | 1 IU | Factor ix non-recombinant | v1, posted March 10, 2026 |
| 2Q25 | $1.377 | +$0.036 | 1 IU | Factor ix non-recombinant | v1, posted March 10, 2026 |
| 1Q25 | $1.341 | −$0.068 | 1 IU | Factor ix non-recombinant | v1, posted December 19, 2025 |
| 4Q24 | $1.409 | +$0.016 | 1 IU | Factor ix non-recombinant | v1, posted June 11, 2025 |
| 3Q24 | $1.393 | +$0.07 | 1 IU | Factor ix non-recombinant | v1, posted June 11, 2025 |
| 2Q24 | $1.323 | +$0.001 | 1 IU | Factor ix non-recombinant | v1, posted March 11, 2025 |
| 1Q24 | $1.322 | +$0.002 | 1 IU | Factor ix non-recombinant | v1, posted December 19, 2024 |
| 4Q23 | $1.32 | +$0.023 | 1 IU | Factor ix non-recombinant | v1, posted October 10, 2024 |
| 3Q23 | $1.297 | +$0.064 | 1 IU | Factor ix non-recombinant | v1, posted June 5, 2024 |
| 2Q23 | $1.233 | +$0.001 | 1 IU | Factor ix non-recombinant | v1, posted February 23, 2024 |
| 1Q23 | $1.232 | +$0.007 | 1 IU | Factor ix non-recombinant | v1, posted December 6, 2023 |
| 4Q22 | $1.225 | +$0.061 | 1 IU | Factor ix non-recombinant | v1, posted June 22, 2023 |
| 3Q22 | $1.164 | −$0.019 | 1 IU | Factor ix non-recombinant | v1, posted June 9, 2023 |
| 2Q22 | $1.183 | +$0.018 | 1 IU | Factor ix non-recombinant | v1, posted December 14, 2022 |
| 1Q22 | $1.165 | $0.00 | 1 IU | Factor ix non-recombinant | v1, posted June 8, 2022 |
| 4Q21 | $1.165 | +$0.035 | 1 IU | Factor ix non-recombinant | v1, posted June 2, 2022 |
| 3Q21 | $1.13 | −$0.025 | 1 IU | Factor ix non-recombinant | v1, posted June 2, 2022 |
| 2Q21 | $1.155 | −$0.037 | 1 IU | Factor ix non-recombinant | v1, posted March 1, 2022 |
| 1Q21 | $1.192 | – | 1 IU | Factor ix non-recombinant | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.